Acrospire Investment Management LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 21 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$90,000
-25.0%
14,609
-25.7%
0.07%
+51.0%
Q4 2016$120,000
+96.7%
19,653
+135.2%
0.05%
+19.5%
Q3 2016$61,000
-14.1%
8,355
-1.2%
0.04%
-22.6%
Q2 2016$71,0008,4550.05%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders